Constitutive single nucleotide polymorphisms (SNP) assessment for predicting tolerability and efficacy of triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) in patients (pts) with liver metastases from colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228).
2014 ◽
Vol 32
(15_suppl)
◽
pp. 3593-3593
Keyword(s):
2014 ◽
Vol 32
(15_suppl)
◽
pp. 3589-3589
◽
2015 ◽
Vol 14
(2)
◽
pp. 5390-5398
◽
2019 ◽
Vol 25
(4)
◽
pp. 1579-1587
◽
2013 ◽
2007 ◽
Vol 102
◽
pp. S259